Professional Role and Company Overview
Peter Meinhold, Ph.D. is the Co-Founder and Chief Technology Officer (CTO) of Provivi Inc., a high-growth agricultural technology company headquartered in Santa Monica, California. Provivi, founded in 2013 by Dr. Meinhold together with Dr. Pedro Coelho and 2018 Nobel Laureate Dr. Frances Arnold, specializes in developing innovative pheromone-based solutions to protect crops from pests. The company focuses on natural, preventive pest control that reduces reliance on traditional chemical pesticides through scalable, cost-effective pheromone production.
Career and Entrepreneurial Background
Dr. Meinhold is an industrial biotech and agtech entrepreneur with a multidisciplinary background rooted in biotechnology and physics. Originally from Germany, he holds a Diploma in Biotechnology from the University of Applied Sciences Weihenstephan, Germany, and a Ph.D. in Physics (experimental cosmology) from the University of California, Berkeley. Before co-founding Provivi, he served as a co-founder and Director of Research at Gevo, Inc., an early biofuels company known for cost-effective renewable fuel production methodologies.
His technical expertise includes genome engineering, demonstrated by work redesigning the yeast genome to enable bio-based production of value-added chemicals such as isobutanol, replacing ethanol fermentation pathways. This technical acumen underpins Provivi’s pioneering advances in biochemical pheromone synthesis for agricultural use.
Company Financing and Growth Milestones
Provivi has successfully secured substantial capital to scale its technology and market presence, including:
- $85 million in Series C funding (October 2019) to advance pheromone production and commercial deployment.
- A $20 million venture loan facility (June 2020) provided by Horizon Technology Finance, reinforcing its financial base for technology scale-up.
Provivi’s pheromone production has been demonstrated at pilot plant scale (Bio Base Europe Pilot Plant, 2019), positioning the company for commercial scalability and expanding adoption.
Technology and Market Positioning
Provivi’s technology utilizes pheromones as eco-friendly agents to disrupt insect mating cycles and protect row crops from major pests without chemical pesticides. This approach aligns with increasing regulatory and market demand for sustainable agricultural technologies. Provivi’s solutions are positioned as preventive tools that leverage state-of-the-art biotechnology to improve outcomes for global farmers.
Industry recognition highlights Peter Meinhold among the top founders in the US agriculture technology space and evidences a strong focus on leveraging synthetic biology and industrial biotech to create scalable, cost-effective pest control methods.
Professional Network and Collaborations
- Co-founder of Provivi alongside Dr. Pedro Coelho and Nobel Laureate Dr. Frances Arnold, indicating a high-caliber leadership team with distinguished scientific credentials.
- Previously collaborated with Frances Arnold since 2005, including at Gevo, underscoring a longstanding partnership in pioneering bio-based industrial solutions.
- His expertise is recognized within professional organizations such as AIChE (American Institute of Chemical Engineers), where he is featured publicly as an agtech and industrial biotech entrepreneur.
Recent Industry Engagements
- Featured as a panelist in a Caltech Life Sciences Entrepreneur forum (Winter 2025), reinforcing his role as an influential thought leader in life sciences innovation.
- Continues to publish and contribute scientifically in pheromone synthesis and pest management, as noted in presentations and conference abstracts (e.g., agricultural innovation forums in 2023).
Key actionable insights include his strong technical and entrepreneurial leadership in pheromone-based pest control, backed by robust funding rounds and operational scaling. Provivi’s disruptive technology focuses on sustainability and regulatory compliance, areas that continue to transform modern agriculture. Dr. Meinhold’s extensive expertise in industrial biotechnology, combined with high-profile scientific partnerships, make him a pivotal figure in advancing scalable agro-biotech innovations.
